UFT in esophageal cancer: a report of two cases
Kagami, Y.; Sakurai, T.; Nishio, M.; Narimatsu, N.; Saitoh, A.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3148-3150
1987
ISSN/ISBN: 0385-0684 PMID: 3118816 Document Number: 301480
We report two patients with esophageal cancer who responded to UFT. The patients were a 71-year-old female and a 61-year-old male, both of whom had recurrent disease in the esophagus or abdominal lymph nodes. They had received previous treatment consisting of radiotherapy and chemotherapy containing cisplatin, methotrexate and peplomycin. Each patient was administered UFT 400 mg/day p.o. No toxic effect was seen.